Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Anticarcinogenic Agents MeSH Descriptor Data 2026


MeSH Heading
Anticarcinogenic Agents
Tree Number(s)
D27.505.696.706.018
D27.505.954.248.125
D27.720.799.018
Unique ID
D016588
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016588
Annotation
do not confuse with ANTINEOPLASTIC AGENTS which treat or affect cancer already developed while ANTICARCINOGENIC AGENTS prevent or reduce the development of cancer; note entry term ANTI-CARCINOGENIC EFFECT: use only for the anti-carcinogenic effect of a chemical substance
Scope Note
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved.
Entry Term(s)
Anti-Carcinogenic Agents
Anti-Carcinogenic Drugs
Anti-Carcinogenic Effect
Anti-Carcinogenic Effects
Anticarcinogenic Drugs
Anticarcinogenic Effect
Anticarcinogenic Effects
Anticarcinogens
Registry Numbers
0
NLM Classification #
QV 269
See Also
Antimutagenic Agents
Antineoplastic Agents
Public MeSH Note
92
History Note
92
Date Introduced
1992/01/01
Last Updated
2014/06/25
Anticarcinogenic Agents Preferred
Anticarcinogenic Effect Related
page delivered in 0.153s